IP Library Granted Patent US 8,957,095
Granted Patent B2
US 8,957,095 · App. 13/504,084 · Granted Feb 17, 2015

Treatment of sunburn using analgesics and antihistamines

Inventors: Talal Sheena (Jamul, CA); Melwyn Abreo (Jamul, CA)
Assignee: Sephoris Pharmaceuticals, LLC
A61K31/135A61K31/192A61K31/435A61K31/4402A61K31/444A61K31/495A61K31/5415A61K31/554A61K31/60A61K45/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,957,095
App. No.
13/504,084
Granted
Feb 17, 2015
Kind
B2
Abstract

Combination compositions and kits comprising an analgesic and an antihistamine are provided as well as methods of use in treating sunburn.

Claims (6)

1. A method of treating pain or discomfort resulting from a sunburn in a subject in need of such treatment, said method comprising orally administering to said subject a combined therapeutically effective amount of ibuprofen and chlorpheniramine, or pharmaceutically acceptable salt thereof, wherein the dose amount of ibuprofen is from 50 mg to 800 mg, and the dose amount of chlorpheniramine is from 2 mg to 8 mg.

2. The method according to claim 1 , wherein said combined therapeutically effective amount of ibuprofen and chlorpheniramine, or pharmaceutically acceptable salt thereof, are co-formulated to form at least a portion of a single dosage unit.

3. The method according to claim 1 , wherein said combined therapeutically effective amount of ibuprofen and chlorpheniramine, or pharmaceutically acceptable salt thereof, are individually formulated to form separate dosage units.

4. The method according to claim 3 , wherein said dosage units are for use in administering 2 to 6 times a day.

5. The method according to claim 1 , wherein said combined therapeutically effective amount of ibuprofen and chlorpheniramine, or pharmaceutically acceptable salt thereof, are free of any additional active agent.

6. The method according to claim 1 , wherein the dose amount of ibuprofen or pharmaceutically acceptable salt thereof, is from 200 mg to 400 mg, and wherein the dose amount of chlorpheniramine or pharmaceutically acceptable salt thereof is 4 mg.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 8, 2012
From: SHEENA, TALAL; ABREO, MELWYN
To: SEPHORIS PHARMACEUTICALS, LLC
Reel/Frame 028346/0727 →
Continuity (2)
Provisional Application 61254803 · Oct 26, 2009
Related Publication 20120225914A1 · Sep 6, 2012